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INTRODUCTION
Asthma is a complex disorder, characterized by airway inflammation that involves the interaction of genetic and environmental factors. The genes predisposing to asthma are likely to contain polymorphisms that modify function. Tumour necrosis factor alpha (TNFα) is a potent inflammatory cytokine whose encoding gene lies on the short arm of Chromosome 6.
1 TNFα gene may influence asthma through modulation of non-specific inflammation. 2 . The TNFα -308 promoter polymorphism is a bi-allelic G (named TNF1 allele) to A (named TNF2 allele) polymorphism, 3 and the TNF2 allele is associated with elevated TNFα levels in plasma and broncho-alveolar lavage fluid from asthmatic airways. 4, 5 Thus, the central role of airway inflammation in asthma and the increased levels of TNFα in asthmatic lungs suggested that functional variants of the TNFα gene could be important in this disease.
A number of studies have assessed the association of the TNFα -308 promoter polymorphism with asthma in different populations; however, the results are inconsistent and inconclusive. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Different methodologies have been used but in particular most of the studies used a small sample size and it is therefore not surprising that there has been a lack of replication between the various studies. By using all the available published data to increase the statistical power, it was hypothesised that a meta-analysis might allow plausible candidate genes to be excluded and causative genes to be identified with reliability. Therefore, we performed a meta-analysis of all of the published case-control studies to ascertain whether the polymorphisms of TNFα -308 gene promoter increased the risk of asthma.
MATERIALS and METHODS

Study Selection
The MEDLINE database was comprehensively searched (last updated search being October 2005), using '_PubMed_' and '_Highwire_' search engines. The keywords used were as follows: asthma, asthma genetics, tumour necrosis factor AND polymorphism or variant or genotype. We also manually searched the reference lists of relevant publications for additional studies.
To be included in the meta-analysis, studies had to meet the following criteria: a) the design had to be a case-control study; b) the outcome had to be asthma and c) there had to be at least two comparison groups (asthma vs control groups). Participants could be of any age. Studies were excluded if one of the following existed: a) the design was based on family or sibling-pairs; b) the genotype frequency was not reported; or c) there was insufficient information for extraction of data.
As far as defining asthma was concerned, we accepted the asthma definition in the individual studies and documented this in our analysis.
Data Extraction and inclusion criteria
A standardized reporting form was used to abstract the following data from each publication including: the first author's name, the year of publication, the country in which the study was conducted, ethnicity, the study design, age range of study subjects, the sample size, asthma definition, asthma-related phenotypes and the genotyping methods used. Data were extracted independently and in duplicate by two investigators (JM Gao and GL Shan). The results were compared and disagreements were resolved by consensus.
Statistical Analysis
A logistic regression model was used to assess the overall genetic effect of TNFα -308 gene on having asthma. To examine the risk of asthma with a specific polymorphism of the TNFα -308 gene, we pooled the ORs from each study weighted by the inverse of variance. A random-effects model was used for the analysis which considered both within-and between-study variation. 26 Effects of ethnicity on the pooled ORs were examined with the meta-regression method. 27, 28 Sensitivity analysis was conducted to examine whether the inclusion criteria affected the pooled ORs. We included the study by Beghe (19) , which has been shown to be in Hardy-Weinberg disequilibrium (p=0.018). We then compared the pooled ORs with the results from the main analysis.
Heterogeneity among studies was examined with the Q, H, and I 2 statistics. 29 A P-value <0.1 was consider significant for Q statistic; H <1.2 suggests no heterogeneity among studies; and I 2 is interpreted as the proportion of total variation contributed by between-study variation. Publication bias was examined with funnel plots, and with the Begg test and Egger test. [30] [31] [32] If there is evidence of publication bias, the funnel plot is noticeably asymmetric. For the Begg and Egger test, the significance level was set at 0.1. Statistical analyses were performed with SAS statistical software (version 8.2, SAS Inc, Cary, NC).
RESULTS
Characteristics of included studies
We identified 23 publications that had evaluated the association of TNFα -308 gene polymorphism with asthma. Eight studies were excluded for the following reasons: sibling-paired and family-based study design (n = 2), 8, 25 no allele or genotyping frequency (n = 3), 7, 14, 20 and analysis of the TNF β (Lymphotoxin-α, LTα) NcoI polymorphism rather than TNFα (n = 5). [33] [34] [35] [36] [37] As detailed in Table 1 , 15 original case-control studies, comprising 2409 patients with asthma and 3266 controls, were included in this meta-analysis. 6, 9-13, 15-19, 21-24 Seven of them were performed in Caucasian subjects, 6, 9, 11-13, 16, 24 , 2 in Italian subjects 18, 19 , 4 in East Asian populations 17, [21] [22] [23] , 1 in a South Asian population, 12 2 in mixed race cohort 10, 15 . Four studies involved paediatric subjects alone 13, 21, 23, 24 , 3 included both children and adults 6, 18, 22 and 8 recruited adults only 9-12, 15-17, 19, . Seven studies extended their examination to the TNFα neighboring gene: lymphotoxin (LT) α variant and asthma 6, [15] [16] [17] [22] [23] [24] , 2 of these showed an association of LTα NcoI polymorphism with asthma. 6, 24 PCR-based genotyping method was mentioned in each study. Four studies particularly stated that double-blind genotyping was conducted. (6, 10, 12, 13) Association between TNF2 allele and asthma
As shown in Table 1 , nine studies found a positive association between TNF2 and asthma; 6, 9, 10, 12, 15, 17, 21, 23, 24 Five studies reported a negative association; 11, 13, 16, 18, 19 One study reported a positive association between TNF1 and asthma. 22 Nine of 15 publications indicated Hardy-Weinberg equilibrium in their subjects; 9, 11, 12, 16, 17, [21] [22] [23] [24] we calculated Hardy-Weinberg equilibrium for the remaining 6 publications and found that only Beghe's study was in Hardy-Weinberg disequilibrium (p=0.018). 19 There was a statistically significant heterogeneity among the odds risks among the included studies (Q test: P<0.01; H=1.98; I 2 =0.75). Without inclusion of Beghe's study, the overall pooled OR for asthma susceptibility was 1.37 (95%CI=1.02 to 1.84, P=0.04) for TNF2 carriers compared with TNF1 carriers. When Beghe's study was included, the overall pooled OR did not change (OR=1.36, 95% CI=1.03 to 1.79, P=0.03) ( Fig. 1) 
Association between genotypes of TNFα -308 and asthma
Thirteen publications reported the genotype frequency of TNFα -308 in asthmatics and controls (shown in Table 2 ). Eight publications that observed Hardy-Weinberg equilibrium were pooled to examine the effect of TNF2/2 homozygote on asthma susceptibility. The overall genetic effect using logistic regression showed that the polymorphisms of TNFα -308 were significantly associated with a risk of having asthma (P<0.01). (Fig. 2B) .
We compared the influence of two major genotypes, namely TNF2/1 heterozygote and TNF1/1 homozygote, on asthma in 12 publications. With the removal of Beghe's study, the pooled OR was elevated at 1.47 (95% CI=1.01 to 2.13, P=0.045) and there was statistically significant heterogeneity among 11 publications (Q test: P<0.01; H=1.97; I 2 =0.74). With inclusion of Beghe's study, the pooled OR was increased at 1.48 (95% CI=1.04 to 2.10, P=0.03) (Fig. 2C ).
There was little evidence of publication bias. P-values obtained from the Begg test and Egger test were >0.2 for all studies with the exception of the comparison between TNF 2/1 heterogeneity and TNF1/1 homozygote (P=0.04) ( Table 3 ). However, funnel plots ( Fig. 3A-D) showed some asymmetry, reflecting a relative absence of studies with both small numbers and larger effects for comparisons between TNF2 allele and TNF1 allele, TNF2/2 homozygote and TNF2/1 heterozygote, TNF2/2 homozygote and TNF2/1 heterozygote. Equally there were studies with both small numbers and small or null effects for comparison between TNF 2/1 heterozygote and TNF1/1 homozygote.
DISCUSSION
The data from this meta-analysis clearly suggests that the TNF2 allele is a genetic contributor to overall asthma susceptibility. We observed that the TNF2/2 homozygote had a stronger association with asthma susceptibility than TNF 2/1 heterozygote, indicating a dose response. These results suggest a possible beneficial role for the TNF1 allele versus the TNF2 allele in asthma as well as there being synergy of the TNF2-TNF2 alleles. The TNF2/2 homozygote represents a greater risk factor for the development of asthma. These findings are consistent with TNFα contributing to asthma inflammation both in vitro and in vivo. This reflects a direct functional effect of the TNFα gene through its upregulation of TNFα levels in asthma.
Based on known or presumed mechanisms of disease pathophysiology, candidate gene strategies provide a useful approach for evaluating gene-disease associations. However, candidate gene case-control studies have been criticized because of a lack of replication. Some TNFα studies have found positive associations between TNF2 allele and asthma, but others have not. Several factors may be influencing these differences. Firstly, if another variant in, or near, the TNF α gene was the causal variant, the true association could easily be missed. Different linkage disequilibrium patterns with the functional variant may lead to variable results in different populations. It is feasible that the TNFα gene variant is playing a role in asthma in cooperation with other gene variants exhibiting a more limited biology. Previous studies have shown that there is a strong linkage disequilibrium between TNFα and LTα polymorphism (D/Dmax = 1, P<0.0001). 38 A haplotype analysis by Bilolikar et al demonstrated that LTα 252A/TNF2 combination was associated with a markedly increased risk for both asthma and infant wheezing. 24 Randolph's study supported the haplotype LTα-1/LTα 4371T/TNF1/TNF1078G being associated with both asthma overall and asthmatic phenotypes. 25 Of note, the TNFα gene is found within a 7kb section of the informative major histocompatibility complex (MHC) class III region. Due to the close proximity of the TNF locus to HLA loci, linkage disequilibrium exists with several HLA alleles. For example, TNF2 is strongly associated with the HLA A1, B8 and DR3 alleles. 39 Moreover, Moffatt et al found that the extended haplotype LTα-1/TNF2/HLA-DRB2 was associated with asthma (OR=6.68, P=0.002) and even more strongly associated with bronchial hyperresponsiveness (OR=21.9, P<0.0001) in a study of over 1000 patients. 7 Secondly, several asthma association studies have shown inconsistent results in Caucasian versus Asian populations. Seemingly racial differences in genetic risk are attributable, however, the current evidence is that genetic effects are usually consistent across human populations. 40 Small sample size, study design flaws, population stratification, genotyping error and other biases may be more common reasons than true racial heterogeneity for the observed discrepancies between studies addressing genetic risks. 41 Specific environmental exposures (e.g. smoking, allergen exposure) is another confounding factor for a disease with a strong gene-environmental interaction in explaining the inconsistency among observational studies. 42, 43 There are several limitations that should be considered when interpreting our group.bmj.com on October 13, 2017 -Published by http://thorax.bmj.com/ Downloaded from results. First is that the pooled ORs were obtained from the heterogeneous studies. Second is that asthma itself is heterogeneous and as such the divergent inclusion criteria among patient groups might also lead to difficulties in pooling the various studies. Thirdly the present meta-analysis was restricted to Englishlanguage publications. The fourth limitation is publication bias. Although significance tests did not suggest the presence of publication bias for most studies, funnel plots did not provide totally consistent results. The presence of possible bias could lead to an underestimation of the effect sizes of TNF2 allele vs TNF1 allele, TNF2/2 homozygote vs TNF2/1 heterozygote, and TNF 2/2 homozygote vs TNF 2/1 heterozygote, but overestimation for TNF 2/1 heterozygote vs TNF1/1 homozygote.
Our data suggest that the TNF2 allele may be a risk factor in the aetiology of asthma. The pooled ORs in this study, both with respect to the TNF2 allele and the TNF2/2 homozygote suggest a modest but definite genetic effect. A larger study population needs to be assessed to help answer the question of whether a given genetic variant confers susceptibility to specific asthma phenotypes or not. 44 The early identification of children at genetic risk of asthma has the potential to offer new approaches to the prevention of asthma. The involvement of particular genes will identify particular clinical courses and anticipate response to therapy. 
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